HDL and SARS CoV-2: emerging theragnostic implications.

Area of Science:

• Cardiovascular Biology
• Immunology
• Infectious Diseases

Background:

• High-density lipoproteins (HDL) are multifunctional particles involved in lipid transport and innate immunity.
• HDLs may have evolved as a defense mechanism against pathogens.
• Emerging evidence links HDL levels to infectious disease outcomes.

Purpose of the Study:

• To explore the role of HDL in the context of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
• To investigate HDL's influence on SARS-CoV-2 susceptibility and disease severity.
• To evaluate HDL as a potential therapeutic target for COVID-19.

Main Methods:

• Review of existing literature on HDL function and SARS-CoV-2 pathogenesis.
• Analysis of clinical data correlating HDL levels with COVID-19 outcomes (if applicable).
• In vitro or in vivo studies investigating HDL-pathogen interactions (if applicable).

Main Results:

• HDL particles possess inherent antimicrobial properties.
• Lower HDL levels are associated with increased susceptibility to SARS-CoV-2 infection.
• Compromised HDL function correlates with more severe COVID-19 complications.

Conclusions:

• HDL plays a significant role in the host defense against viral infections like SARS-CoV-2.
• HDL levels and functionality are critical determinants of COVID-19 severity.
• Targeting HDL represents a promising therapeutic strategy for managing SARS-CoV-2 infection.